Trump’s Health Agency Signals Moving Forward on Drug Price Talks

President Donald Trump’s Medicare agency is seeking to bring more transparency to the US government’s drug price negotiation program, indicating plans to move forward with the second round of the program initiated by the Biden administration.

“Lowering the cost of prescription drugs for Americans is a top priority of President Trump and his Administration,” the Centers for Medicare & Medicaid Services said in a statement Wednesday.

“As the second cycle begins under the Trump Administration, CMS is committed to incorporating lessons learned to date from the program and to considering opportunities to bring greater transparency in the Negotiation Program.” ...